eMERGE

Post-event Pain algorithm

Pain is a personal, multidimensional experience in which genetic biomarkers has a main role in determining pain sensitivity, perception and tolerance. Pain is a major concern for surgical patients and post-operative pain management still present a major challenge both in inpatient or outpatient settings. Apart from genetic factors, there are many other variables that may affect pain perception for example, pretreated patients may require less post-surgical medications, and they may recover more quickly.

Owner Phenotyping Groups: 
View Phenotyping Groups: 
Final

Red Blood Cell Indices

Laboratory results for ESR and RBC indices (hemoglobin, MCV, MCH, RDW… etc) should be extracted from the Laboratory databases. For Mayo, from January 1994 till October 2009, ESR and RBC test results were populated for our 3336 participants. All samples were collected on an outpatient basis. Samples collected during an inpatient hospitalization (admit date ≤ collection date ≤ discharge date) should be excluded unless this sample was the only one available for a patient.

Owner Phenotyping Groups: 
View Phenotyping Groups: 
Final

SLE (Systemic Lupus Erythematosus) using SLICC (Systemic Lupus Internation Collaborating Clinics) Criteria

Systemic Lupus Erythematosus (SLE) is a chronic, systemic autoimmune disease that can affect many parts of the body including skin, lungs, brain, heart, kidneys, joints, and blood vessels. SLE presentation can vary significantly between patients. Because of this, it can be challenging to identify a patient as having SLE. Between 300,000 and 2,000,000 people in the US are estimated to have SLE. Determination of an exact number of people affected is challenging as the disease is difficult to identify given the diverse presentations and the length of time it may take for symptoms to appear.

Owner Phenotyping Groups: 
View Phenotyping Groups: 
Final

Statins and MACE

Phenotype Description:  Patients on statins for primary prevention who develop an AMI or 1st AMI. 

Below are algorithms used to identify AMI and 1st AMI cohort at BioVU. If you have questions regarding any of the information presented on this page, you may contact either:

Wei-Qi Wei at wei-qi.wei@vanderbilt.edu

Joshua Denny at josh.denny@vanderbilt.edu

 

             

Owner Phenotyping Groups: 
View Phenotyping Groups: 
Final

Type 2 Diabetes - PRS Evaluation

NOTE: 

The following files were updated on 4/9/2021 so that the output of the #feature table in the eMERGE_IV_OMOP_T2DM_PRS_algorithm script matches the data dictionary.

Files:

  • T2DM_DD_Feature_Count_OMOP_2021049.csv
  • eMERGE_IV_OMOP_T2DM_PRS_algorithm_20210409.txt
  • eMERGE_IV_OMOP_T2DM_PRS_algorithm_20210409.zip

 

 

Owner Phenotyping Groups: 
View Phenotyping Groups: 
Final

Pages